Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants
MS201491_0001
Phase 1 other active
Quick answer
Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants for Healthy is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- other
- Status
- active